Meitav Investment House’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Sell |
21,185
-12,085
| -36% | -$844K | 0.02% | 132 |
|
|
2025
Q1 | $2.45M | Sell |
33,270
-205,000
| -86% | -$15.1M | 0.05% | 105 |
|
|
2024
Q4 | $15.6M | Buy |
238,270
+205,000
| +616% | +$13.4M | 0.26% | 74 |
|
|
2024
Q3 | $2.59M | Sell |
33,270
-12,123
| -27% | -$945K | 0.04% | 107 |
|
|
2024
Q2 | $3.54M | Hold |
45,393
| – | – | 0.06% | 102 |
|
|
2024
Q1 | $3.08M | Hold |
45,393
| – | – | 0.06% | 97 |
|
|
2023
Q4 | $3.06M | Sell |
45,393
-30,683
| -40% | -$2.07M | 0.04% | 135 |
|
|
2023
Q3 | $5.16M | Sell |
76,076
-989
| -1% | -$67K | 0.08% | 121 |
|
|
2023
Q2 | $5.49M | Hold |
77,065
| – | – | 0.09% | 125 |
|
|
2023
Q1 | $5.68M | Sell |
77,065
-7,811
| -9% | -$576K | 0.1% | 139 |
|
|
2022
Q4 | $5.77M | Sell |
84,876
-300
| -0.4% | -$20.4K | 0.1% | 144 |
|
|
2022
Q3 | $4.68M | Sell |
85,176
-19,147
| -18% | -$1.05M | 0.08% | 146 |
|
|
2022
Q2 | $6.89M | Sell |
104,323
-615
| -0.6% | -$40.6K | 0.12% | 124 |
|
|
2022
Q1 | $6.96M | Buy |
104,938
+38,822
| +59% | +$2.58M | 0.1% | 142 |
|
|
2021
Q4 | $3.86M | Hold |
66,116
| – | – | 0.06% | 173 |
|
|
2021
Q3 | $3.97M | Buy |
66,116
+2,716
| +4% | +$163K | 0.07% | 174 |
|
|
2021
Q2 | $3.8M | Sell |
63,400
-100
| -0.2% | -$5.99K | 0.1% | 138 |
|
|
2021
Q1 | $3.16K | Buy |
63,500
+52,410
| +473% | +$2.61K | 0.09% | 140 |
|
|
2020
Q4 | $556K | Buy |
+11,090
| New | +$556K | 0.02% | 265 |
|
|
2019
Q3 | – | Sell |
-6,000
| Closed | -$246K | – | 444 |
|
|
2019
Q2 | $246K | Sell |
6,000
-2,000
| -25% | -$82K | 0.02% | 367 |
|
|
2019
Q1 | $344K | Sell |
8,000
-2,000
| -20% | -$86K | 0.02% | 294 |
|
|
2018
Q4 | $373K | Hold |
10,000
| – | – | 0.02% | 227 |
|
|
2018
Q3 | $398K | Hold |
10,000
| – | – | 0.02% | 359 |
|
|
2018
Q2 | $349K | Hold |
10,000
| – | – | 0.02% | 360 |
|
|
2018
Q1 | $350K | Buy |
+10,000
| New | +$350K | 0.02% | 276 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 201 |
|